Skip to main content
Log in

Evaluation of the Antiradiation Efficiency of Flagellin in Experiments on Mice

  • MODIFICATION OF RADIATION EFFECTS
  • Published:
Biology Bulletin Aims and scope Submit manuscript

Abstract

In experiments on SPF mice, the authors evaluated the radio-protective effectiveness of the recombinant Flagellin, developed at the Institute of High-Purity Preparations (St. Petersburg), administered at a wide range of doses of 0.004–2 mg/kg for 30 min prior to X-ray irradiation in the dose range of 7–10 Gy. The effectiveness of Flagellin was evaluated in terms of 30-day survival rates of the mice, the average life expectancy, and according to the DMF criterion for bone marrow death. The DMF values were 1.24–1.23–1.22 at the level of LD16, LD50, and LD84. ED50 approximately equals 25 μg/kg. The dose-response effect of Flagellin was evaluated to reach a plateau at a dose of 0.2 mg/kg.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

REFERENCES

  1. Burdelya, L.G., Krivokrysenko, V.I., Tallant, T.C., et al., An agonist of toll-lair receptor 5 has radioprotective activity in mouse and primate models, Science, 2008, vol. 320, no. 5873, pp. 226–230.

    Article  CAS  Google Scholar 

  2. Krivokrysenko, V.N., Shakhov, A.N., Gudkov, A.V., and Feinstein, E., Identification of G-CSF and IL-6 as candidate biomarkers of GBLB502 efficacy as a medical radiation countermeasure, JPET Fast Forward, 2012, pp. 1–46. https://doi.org/10.1124/jpet.112.196071

    Book  Google Scholar 

  3. Al’-Shekhadat, R.I., Matyunina, E.A., Sharafutdinova, T.A., et al., Obtaining and studying the properties of recombinant bacterial flagellin, Khim. Radiats. Bezop., 2012, spec. issue, pp. 109–116.

  4. Grebenyuk, A.N., Aksenova, N.V., Petrov, A.V., et al., Obtaining various variants of recombinant flagellin and assessing their radioprotective effectiveness, Vestn. Ros. Voen.-Med. Akad., 2013, vol. 43, no. 3, pp. 75–80.

    Google Scholar 

  5. Sofronov, G.A., Murzina, E.V., Bolekhan, V.N., et al., Promising directions for the use of recombinant flagellin-based drugs, Med. Akad. Zh., 2017, no. 2, pp. 7–20.

  6. Murzina, E.V., Sofronov, G.A., Aksenova, N.V., et al., Antiradiation properties of bacterial flagellin, Izv. Ros. Voen.-Med. Akad., 2017, vol. 36, no. 2, suppl. 1, р. 242.

  7. Rozhdestvenskii, L.M., Konchalovskii, M.V., Baranov, A.E., et al., Possibility of using the drug Betaleukin (interleukin-1β) for emergency therapeutic care in acute emergency human exposure, in V Ross. Nats. Kongr. “Chelovek i lekarstvo”, Moskva, 21–25 aprelya 1998 (V Russ. Natl. Congr. “Man and Medicine,” Moscow, April 21–25, 1998), Moscow, 1998, p. 454.

  8. Direktiva 2010/63/EU Evropeiskogo parlamenta i Soveta evropeiskogo soyuza po okhrane zhivotnykh, ispol’zuemykh v nauchnykh tselyakh (Directive 2010/63/ EU of the European Parliament and the Council of the European Union on the Protection of Animals Used for Scientific Purposes), St. Petersburg: Rus-Lasa NP Ob’’edinenie Spetsialistov po Rabote s Laboratornymi Zhivotnymi, 2012.

  9. Popova, E.B., Research planning and analysis of dose–effect relationships for toxic and medicinal compounds, Doctoral (Med.) Dissertation, St. Petersburg, 2010.

  10. O’Neill, L. and Green, C., Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants, J. Leukocyte Biol., 1998, vol. 63, pp. 650–657.

    Article  Google Scholar 

  11. Neta, R., Cytokines in radioprotection and therapy of radiation injury, Biotherapy, 1988, no. 1, pp. 41–45.

  12. Grebenyuk, A.N. and Legeza, V.I., Protivoluchevye svoistva interleikina-1 (Anti-Radiation Properties of Interleukin-1), St. Petersburg: OOO Izd. Foliant, 2012.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. I. Lisina.

Ethics declarations

Conflict of interest. The authors declare that they have no conflict of interest.

Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lisina, N.I., Shchegoleva, R.A., Shlyakova, T.G. et al. Evaluation of the Antiradiation Efficiency of Flagellin in Experiments on Mice. Biol Bull Russ Acad Sci 47, 1531–1535 (2020). https://doi.org/10.1134/S1062359020110084

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1062359020110084

Keywords:

Navigation